ArticleUnited European gastroenterology journal2020

Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study.

Nathaniel Aviv Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.